Eric Meldrum

Biography

Responsible for the strategy and operational management of pre-clinical drug discovery and development Specialist in drug development, having worked for major pharmaceutical groups and biotechnology companies Former Chief Scientific Officer at Genkyotex and at 3V Biosciences, where he developed portfolios of NOX-inhibiting molecules and of molecules targeting the replication of respiratory viruses respectively Former Director of the Asthma Disease Biology Department at GSK, where he was accountable for the biology associated with more than a dozen drug research and development programmes through to Phase 2 of clinical trials

Research Interest

Pharmaceutical Sciences